Muchmore H G, Scott E N, Felton F G, Fromtling R A
Am J Epidemiol. 1980 Jul;112(1):32-8. doi: 10.1093/oxfordjournals.aje.a112974.
Eighty clinical and 28 soil isolates of C. neoformans obtained in Oklahoma were separated into A-D and B-C serotype groups utilizing creatinine-dextrose agar with bromthymol blue. Previously, serotype B-C clinical isolates have been frequent only in patients from Southern California where as many as 50% of the isolates are of this type. In contrast, in patients from the rest of the United States the B-C frequency has been only 6%. Of the 80 C. neoformans isolates from Oklahoma patients, 12 (15%) were serotype B-C. One-half of these 12 Oklahoma patients with serotype B-C isolates had no history of any travel to California, and were long-time residents of Oklahoma. All 28 soil isolates of C. neformans from Oklahoma in this study were serotype A-D. Since serotype B-C recovery from a soil sample has never been reported, attempts are in progress to isolate serotype B-C from the environments of these patients from Oklahoma.
在俄克拉荷马州获得的80株新型隐球菌临床分离株和28株土壤分离株,利用含溴百里酚蓝的肌酐葡萄糖琼脂被分为A - D和B - C血清型组。此前,B - C血清型临床分离株仅在南加州的患者中较为常见,该地区多达50%的分离株为此类型。相比之下,在美国其他地区的患者中,B - C血清型的频率仅为6%。在来自俄克拉荷马州患者的80株新型隐球菌分离株中,12株(15%)为B - C血清型。这12例携带B - C血清型分离株的俄克拉荷马州患者中,有一半没有去过加利福尼亚州的任何旅行史,并且是俄克拉荷马州的长期居民。本研究中来自俄克拉荷马州的所有28株新型隐球菌土壤分离株均为A - D血清型。由于从未有过从土壤样本中分离出B - C血清型的报道,目前正在尝试从这些俄克拉荷马州患者的环境中分离出B - C血清型。